Columbus Circle Investors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-89,052
Closed -$4.38M 304
2016
Q4
$4.38M Sell
89,052
-42,076
-32% -$2.32M 0.06% 194
2016
Q3
$7.86M Buy
+131,128
New +$7.04M 0.08% 183
2016
Q2
Sell
-150,562
Closed -$6.2M 284
2016
Q1
$6.2M Sell
150,562
-68,381
-31% -$2.68M 0.06% 207
2015
Q4
$14.9M Buy
218,943
+58,987
+37% +$3.56M 0.12% 167
2015
Q3
$7.25M Sell
159,956
-121,459
-43% -$7.07M 0.06% 208
2015
Q2
$14.8M Buy
+281,415
New +$11.1M 0.1% 190

Other funds holding PRTA

Columbus Circle Investors's PRTA Position: Q1 2017 in Review

Columbus Circle Investors sold out of Prothena Corp (PRTA) in Q1 2017, closing a stake of 89,052 shares — an estimated $4.38M sold.

Columbus Circle Investors first reported a position in PRTA in Q2 2015 and held it in 6 quarters. The position peaked at $14.9M in Q4 2015. 146 funds tracked by Wall St. Rank hold PRTA as of Q1 2017.

  • Columbus Circle Investors reported no remaining Prothena Corp position as of Q1 2017 after selling out during the quarter.
  • Columbus Circle Investors sold 89,052 Prothena Corp shares in Q1 2017, an estimated $4.38M.
  • Columbus Circle Investors first reported a position in Prothena Corp in Q2 2015 and held it in 6 quarters.
  • Columbus Circle Investors's Prothena Corp position peaked at $14.9M in Q4 2015.
  • 146 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2017.

Based on Columbus Circle Investors's 13F filing for Q1 2017, filed 20 Apr 2017.